NCT01511328Active, not recruiting
Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm
Randomized Implementation of Primary Human Papillomavirus (HPV) Testing in the Organized Screening for Cervical Cancer in Stockholm
Source: ClinicalTrials.gov · Last updated 16 May 2024
Brief summary (registry, in English)
The purpose is to evaluate whether implementation of primary human papillomavirus (HPV) screening in the screening programme for cervical cancer improves the programme in terms of better cancer protection and better cost efficiency.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 270000 (actual)
- First submitted
- 20 Dec 2011
- Start date
- 1 Jan 2012
- Primary completion date
- 30 Jun 2017
- Lead sponsor
- Karolinska Institutet
- Diseases
- Cervical cancer
- NCT number
- NCT01511328
What you commit to
- Study type: Interventional
- Participants enrolled: 270000
- From 1 Jan 2012 to the primary completion date, 30 Jun 2017
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Women between the age 30 and 64 years resident in the Stockholm-Gotland region. No exclusion criteria.
Age in the registry: 30 years to 64 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Karolinska University Hospital Coordinator of this site? Confirm its status | Stockholm | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.